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PV
 First described in 1892
 Incidence of at least 2 per 100 000
 10 decades of investigation - the etiology and
pathophysiology of polycythemia vera still not
fully understood
 William Osler was the first to emphasize that
phenotypic mimicry could confound the
diagnostic process
• Proposed clinical criteria to distinguish
polycythemia vera from other disorders
causing erythrocytosis

Evolution of Diagnostic Criteria

Due to the unique physiology
of erythropoietin,
measurement of the hormone
in the circulation cannot be
relied on to distinguish
between autonomous and
erythropoietin-driven
erythrocytosis

The diagnostic value of EPO has
been debated due to the
increasing availability of
advanced molecular testing

We hypothesized that EPO level
may not provide additional
diagnostic information

Methods
 Retrospective chart review 415 patient records were reviewed.
 161 patients had erythropoietin values checked in their EMRs.
 23 of the 161 patients have diagnosis date missing or JAK2V617F mutation
status missing.
 138 patients included in final analysis
 Logistic regression was used to build a predictive model for the diagnosis of PV
based on EPO value and JAK2V617F mutation status.
• A weakly informative prior was used when there is complete separation in
logistic regression.
 The area under the receiver operating characteristic curve (AUC) was
calculated to evaluate the predictive accuracy.
 A p-value less than 0.05 was considered statistically significant.

The main clinical and hematological characteristics
Table 1

Results
Table 3
The correlation of erythropoietin value with other
variables

Table 2
PPV and NPV of suboptimal EPO level
Erythrop ‹ 3.7
oietin
mU/mL
Level

› 3.7

PV

No PV

51

4

24

59

mU/mL
Sensitivit Specificit
y 68%
y 93.7%

Rho
PPV
92.7%
NPV
71.1%

BMI

P-value
0.33 <0.001

Age

-0.07 0.43

Hb

-0.16 0.053

Hct

-0.3 <0.001

WBC

-0.33 <0.001

Plts

-0.56 <0.001

GFR

-0.09 0.28

Cr

0.18 0.032

Model zero
When we only include erythropoietin in the
model (model 0), it is significantly associated
with PV

OR 0.857; p-value <0.001,
AUC for the model zero is 0.8841
Used for comparative purpose

Model 1
Predictive value of suboptimal erythropoietin
level and JAK2 V617F mutation status
Erythropoietin level is not significantly
associated with the diagnosis of PV
OR 0.960, p-value 0.314
Model 1 give an AUC 0.9587

Model 2
Model 2 shows the predictive value of the
JAK2 V617F for the diagnosis of the PV alone
OR 2142.7; p<0.001
AUC is 0.9467.

Discussion
 Results show that erythropoietin level below the normal range does not bring additional
diagnostic value when JAK2V617F mutation status is positive.
 Additionally, erythropoietin level has a negative correlation with increased BMI and smoking
status, making not reliable diagnostic marker.

 The utility of EPO in differentiating between primary and secondary erythrocytosis is largely
based on early trials prior to the discovery of JAK2.
 Potential limitations of the study include intrinsic bias of retrospective analysis, inability to
standardize bone marrow biopsy findings, incomplete records, and limited number of patients.

 Future direction

